300434 金石亚药
已收盘 08-24 15:00:00
资讯
新帖
简况
金石亚药：8月7日董事郑志勇减持股份合计25万股
证券之星 · 08-10
金石亚药：8月7日董事郑志勇减持股份合计25万股
股市必读：金石亚药新发布《关于子公司参与第十二批全国药品集中采购拟中选的公告》
证券之星 · 08-05
股市必读：金石亚药新发布《关于子公司参与第十二批全国药品集中采购拟中选的公告》
金石亚药：续断壮骨胶囊属于国家中药二类新药
证券之星 · 08-04
金石亚药：续断壮骨胶囊属于国家中药二类新药
金石亚药（300434）披露放弃参股公司增资优先认购权暨关联交易公告，7月17日股价下跌7.62%
证券之星 · 07-17
金石亚药（300434）披露放弃参股公司增资优先认购权暨关联交易公告，7月17日股价下跌7.62%
股市必读：金石亚药（300434）预计2026年1-6月扣非后净利润盈利7612.6万元至9861.96万元
证券之星 · 07-15
股市必读：金石亚药（300434）预计2026年1-6月扣非后净利润盈利7612.6万元至9861.96万元
金石亚药（300434）披露2026年半年度业绩预告，7月14日股价下跌0.75%
证券之星 · 07-14
金石亚药（300434）披露2026年半年度业绩预告，7月14日股价下跌0.75%
金石亚药：创业板上市公司半年度业绩预告无强制披露要求
证券之星 · 07-14
金石亚药：创业板上市公司半年度业绩预告无强制披露要求
金石亚药：目前，公司没有上述产品的获批事项
证券之星 · 07-06
金石亚药：目前，公司没有上述产品的获批事项
6月29日金石亚药（300434）涨停分析：医保目录预期、FDA获批驱动
证券之星 · 06-29
6月29日金石亚药（300434）涨停分析：医保目录预期、FDA获批驱动
金石亚药：公司正积极探索公司业务与ai结合的可能性及应用场景
证券之星 · 06-04
金石亚药：公司正积极探索公司业务与ai结合的可能性及应用场景
金石亚药：带式增强柔性复合管成套技术和设备可应用于石油天然气相关输送管材生产
证券之星 · 06-03
金石亚药：带式增强柔性复合管成套技术和设备可应用于石油天然气相关输送管材生产
金石亚药：公司真空镀膜设备可用于建筑幕墙玻璃，汽车内外饰件、车灯，光学显示产品，水晶玻璃，电子元器件等多种装饰膜和功能膜行业
证券之星 · 06-03
金石亚药：公司真空镀膜设备可用于建筑幕墙玻璃，汽车内外饰件、车灯，光学显示产品，水晶玻璃，电子元器件等多种装饰膜和功能膜行业
金石亚药：公司暂不涉及上述业务
证券之星 · 05-08
金石亚药：公司暂不涉及上述业务
金石亚药(300434.SZ)发布一季度业绩，归母净利润1.16亿元，增长84.59%
智通财经 · 04-23
金石亚药(300434.SZ)发布一季度业绩，归母净利润1.16亿元，增长84.59%
金石亚药(300434)3月31日股东户数2.39万户，较上期减少2.08%
证券之星 · 04-23
金石亚药(300434)3月31日股东户数2.39万户，较上期减少2.08%
股市必读：金石亚药（300434）4月21日董秘有最新回复
证券之星 · 04-22
股市必读：金石亚药（300434）4月21日董秘有最新回复
股市必读：金石亚药（300434）4月3日董秘有最新回复
证券之星 · 04-07
股市必读：金石亚药（300434）4月3日董秘有最新回复
金石亚药(300434.SZ)：多潘立酮片中选接续采购
智通财经网 · 03-02
金石亚药(300434.SZ)：多潘立酮片中选接续采购
股市必读：金石亚药（300434）2月26日董秘有最新回复
证券之星 · 02-27
股市必读：金石亚药（300434）2月26日董秘有最新回复
金石亚药：目前与DeepSeek暂无业务对接
证券之星 · 02-26
金石亚药：目前与DeepSeek暂无业务对接
加载更多
公司概况
公司名称：
四川金石亚洲医药股份有限公司
所属行业：
医药制造业
上市日期：
2015-04-24
主营业务：
四川金石亚洲医药股份有限公司的主营业务是药品及保健食品研发、生产以及销售。公司的主要产品是呼吸系统用药、其他医药产品、保健品及食品、成套生产线、机械配件及其他。
发行价格：
10.57
{"stockData":{"symbol":"300434","market":"SZ","secType":"STK","nameCN":"金石亚药","latestPrice":11.27,"timestamp":1787554995000,"preClose":11.84,"halted":0,"volume":18280720,"delay":0,"changeRate":-0.0481,"floatShares":342000000,"shares":401999999,"eps":0.46,"marketStatus":"已收盘","change":-0.57,"latestTime":"08-24 15:00:00","open":11.84,"high":11.95,"low":11.18,"amount":209000000,"amplitude":0.065,"askPrice":11.27,"askSize":100,"bidPrice":11.26,"bidSize":244,"shortable":0,"etf":0,"ttmEps":0.46,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787621400000},"marketStatusCode":5,"adr":0,"adjPreClose":11.84,"symbolType":"stock","openAndCloseTimeList":[[1787535000000,1787542200000],[1787547600000,1787554800000]],"highLimit":13.02,"lowLimit":10.66,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":401743872,"isCdr":false,"pbRate":1.78,"roa":"--","peRate":24.5,"roe":"4.45%","epsLYR":0.33,"committee":-0.031083,"marketValue":4528000000,"turnoverRate":0.0534,"status":1,"floatMarketCap":3856000000},"requestUrl":"/m/hq/s/300434/","defaultTab":"news","newsList":[{"id":"2658387931","title":"金石亚药：8月7日董事郑志勇减持股份合计25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658387931","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658387931?lang=zh_cn&edition=full","pubTime":"2026-08-10 21:01","pubTimestamp":1786366891,"startTime":"0","endTime":"0","summary":"证券之星消息，根据8月10日市场公开信息、上市公司公告及交易所披露数据整理，金石亚药（300434）最新董监高及相关人员股份变动情况：2026年8月7日公司董事郑志勇共减持公司股份25.0万股，占公司总股本为0.0622%。变动期间公司股价上涨8.84%，8月7日当日收盘报11.45元。金石亚药近半年内的董监高及核心技术人员增减持详情如下：金石亚药的高管列表及最新持股情况如下：该股最近90天内无机构评级。本文数据来源于深圳证券交易所信息披露、金石亚药公告，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000031732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0028","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657417563","title":"股市必读：金石亚药新发布《关于子公司参与第十二批全国药品集中采购拟中选的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657417563","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657417563?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:05","pubTimestamp":1785866716,"startTime":"0","endTime":"0","summary":"公司公告汇总：全资二级子公司浙江迪耳药业双氯芬酸钠缓释片拟中选第十二批全国药品集采，2025年度拟中选规格销售收入622.31万元，占公司当期营收0.60%。公司公告汇总关于子公司参与第十二批全国药品集中采购拟中选的公告四川金石亚洲医药股份有限公司全资二级子公司浙江迪耳药业有限公司参与第十二批国家组织药品集中带量采购，其双氯芬酸钠缓释片拟中选。目前采购协议尚未签订，后续存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500001946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0077","300434"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656350735","title":"金石亚药：续断壮骨胶囊属于国家中药二类新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2656350735","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656350735?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:25","pubTimestamp":1785831928,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)08月04日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的领导您好！公司已研发成功上市“续断壮骨胶囊”是国家中药二类新药吗？主要是用于什么症状？在中药管线储备方面，我们有开展计划吗？谢谢！金石亚药回复：尊敬的投资者，您好！目前，公司已上市的在销产品“续断壮骨胶囊”属于国家中药二类新药，适应症及功效为补肾壮骨，用于原发性骨质疏松症属肝肾不足证。公司目前在研项目相关情况请详见公司定期报告。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400027166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0077","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652428603","title":"金石亚药（300434）披露放弃参股公司增资优先认购权暨关联交易公告，7月17日股价下跌7.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652428603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652428603?lang=zh_cn&edition=full","pubTime":"2026-07-17 22:10","pubTimestamp":1784297432,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，金石亚药报收于10.91元，较前一交易日下跌7.62%，最新总市值为43.83亿元。近日，金石亚药披露《关于放弃参股公司增资优先认购权暨关联交易的公告》。公告显示，公司于2026年7月17日召开董事会，审议通过放弃参股公司杭州领业医药科技有限公司本次增资的优先认购权。公司原持有领业医药32.43%股权，放弃认购后持股比例被动稀释至30.12%。关联董事已回避表决。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700044611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300434","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651830244","title":"股市必读：金石亚药（300434）预计2026年1-6月扣非后净利润盈利7612.6万元至9861.96万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651830244","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651830244?lang=zh_cn&edition=full","pubTime":"2026-07-15 02:22","pubTimestamp":1784053330,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，金石亚药报收于11.85元，下跌0.75%，换手率10.88%，成交量37.22万手，成交额4.36亿元。业绩披露要点业绩预告金石亚药发布业绩预告，预计2026年1-6月扣非后净利润盈利7612.6万元至9861.96万元；归属净利润盈利8606.25万元至1.09亿元。公司公告汇总2026年半年度业绩预告四川金石亚洲医药股份有限公司预计2026年上半年归属于上市公司股东的净利润为8,606.25万元至10,855.61万元，同比增长30.90%至65.12%；扣除非经常性损益后的净利润为7,612.60万元至9,861.96万元，同比增长36.61%至76.98%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500002643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651104243","title":"金石亚药（300434）披露2026年半年度业绩预告，7月14日股价下跌0.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651104243","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651104243?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:33","pubTimestamp":1784039592,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，金石亚药报收于11.85元，较前一交易日下跌0.75%，最新总市值为47.61亿元。该股当日开盘11.95元，最高12.09元，最低11.1元，成交额达4.36亿元，换手率为10.88%。近日，四川金石亚洲医药股份有限公司披露2026年半年度业绩预告。本次业绩预告未经审计，最终数据以2026年半年度报告为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0077","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651178982","title":"金石亚药：创业板上市公司半年度业绩预告无强制披露要求","url":"https://stock-news.laohu8.com/highlight/detail?id=2651178982","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651178982?lang=zh_cn&edition=full","pubTime":"2026-07-14 15:39","pubTimestamp":1784014745,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)07月14日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司什么时候发业绩中报预告？金石亚药回复：尊敬的投资者，您好！根据相关监管规则，创业板上市公司半年度业绩预告无强制披露要求，公司将结合经营数据，综合考量是否披露相关业绩预告。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400024881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0077","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649399642","title":"金石亚药：目前，公司没有上述产品的获批事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2649399642","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649399642?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:27","pubTimestamp":1783326445,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)07月06日在投资者关系平台上答复投资者关心的问题。投资者提问：子公司亚洲制药儿童布洛芬混悬液通过美国FDA仿制药认证，可直接在美国市场销售。这个事情是否是真的？为何在广发，东方财富，都没有看到公司发公告？金石亚药回复：尊敬的投资者，您好！目前，公司没有上述产品的获批事项。在研项目如果有实质性进展，公司将会严格按照相关要求履行信息披露义务。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600021839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0028","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647292023","title":"6月29日金石亚药（300434）涨停分析：医保目录预期、FDA获批驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2647292023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647292023?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:36","pubTimestamp":1782718570,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药6月29日涨停收盘，收盘价10.81元。该股于13点3分涨停，未打开涨停，截止收盘封单资金为1.05亿元，占其流通市值2.84%。6月29日金石亚药涨停的可能因素有：公司于6月27日公告其核心产品“快克”入选2024年国家医保目录谈判范围，市场预期终端放量提升；同期披露子公司亚洲制药获FDA关于布洛芬混悬液ANDA批准，出海进展获关注；此外，近期多家券商发布深度报告，强调其OTC渠道优势及儿科用药细分赛道壁垒。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900017491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300434","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640150645","title":"金石亚药：公司正积极探索公司业务与ai结合的可能性及应用场景","url":"https://stock-news.laohu8.com/highlight/detail?id=2640150645","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640150645?lang=zh_cn&edition=full","pubTime":"2026-06-04 20:51","pubTimestamp":1780577478,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：目前主流创新药公司都引进了AI医疗，贵公司有没有布局AI医疗产业？金石亚药回复：尊敬的投资者，您好！目前ai技术在医药创新领域应用前景非常广泛，公司正积极探索公司业务与ai结合的可能性及应用场景，拥抱技术革新带来的商业机会。敬请广大投资者注意投资风险。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400039404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0077","300434"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640977401","title":"金石亚药：带式增强柔性复合管成套技术和设备可应用于石油天然气相关输送管材生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2640977401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640977401?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:51","pubTimestamp":1780476670,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药06月03日在投资者关系平台上答复投资者关心的问题。公司增强复合塑料管道成套技术和设备为客户定制化产品：钢带类增强复合管道成套设备可应用于市政排水管材生产，钢丝类增强复合管道成套设备可应用于市政给水、工业中低压力流体输送、矿用耐磨管道等领域管材生产，带式增强柔性复合管成套技术和设备可应用于石油天然气相关输送管材生产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300033882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","159019","UGAZ","BK0028","UNG","QGmain","300434","DGAZ","NGmain","BK0239","MNGmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640977286","title":"金石亚药：公司真空镀膜设备可用于建筑幕墙玻璃，汽车内外饰件、车灯，光学显示产品，水晶玻璃，电子元器件等多种装饰膜和功能膜行业","url":"https://stock-news.laohu8.com/highlight/detail?id=2640977286","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640977286?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:51","pubTimestamp":1780476668,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司生产的真空镀膜设备主要可以应用在哪些领域？金石亚药回复：尊敬的投资者，您好！公司真空镀膜设备为客户定制化产品，可用于建筑幕墙玻璃，汽车内外饰件、车灯，光学显示产品，水晶玻璃，电子元器件等多种装饰膜和功能膜行业。同时，公司也在积极探索真空镀膜在新技术领域的研发和应用。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300033881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300434","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633004101","title":"金石亚药：公司暂不涉及上述业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2633004101","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633004101?lang=zh_cn&edition=full","pubTime":"2026-05-08 09:01","pubTimestamp":1778202085,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)05月07日在投资者关系平台上答复投资者关心的问题。投资者提问：3. 氮杂环丁烷小环结构是抗癌、神经、抗病毒创新药的核心骨架，请问贵公司在该类高难度小环中间体领域，是否有布局连续流加氢、电催化等绿色工艺？目前有没有已落地的商业化项目？金石亚药回复：尊敬的投资者，您好！公司暂不涉及上述业务。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800007810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0077","300434"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629856573","title":"金石亚药(300434.SZ)发布一季度业绩，归母净利润1.16亿元，增长84.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629856573","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629856573?lang=zh_cn&edition=full","pubTime":"2026-04-23 23:46","pubTimestamp":1776959218,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金石亚药(300434.SZ)发布2026年第一季度报告，该公司营业收入为3.31亿元，同比增长13.72%。归属于上市公司股东的净利润为1.16亿元，同比增长84.59%。归属于上市公司股东的扣除非经常性损益的净利润为1.09亿元，同比增长89.58%。基本每股收益为0.2888元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433029.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300434"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629884976","title":"金石亚药(300434)3月31日股东户数2.39万户，较上期减少2.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629884976","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629884976?lang=zh_cn&edition=full","pubTime":"2026-04-23 17:36","pubTimestamp":1776936977,"startTime":"0","endTime":"0","summary":"证券之星消息，近日金石亚药披露，截至2026年3月31日公司股东户数为2.39万户，较12月31日减少507.0户，减幅为2.08%。在化学制药行业个股中，金石亚药股东户数低于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.5万户。从股价来看，2025年12月31日至2026年3月31日，金石亚药区间跌幅为3.7%，在此期间股东户数减少507.0户，减幅为2.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300048482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300434","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629052825","title":"股市必读：金石亚药（300434）4月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2629052825","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2629052825?lang=zh_cn&edition=full","pubTime":"2026-04-22 03:04","pubTimestamp":1776798254,"startTime":"0","endTime":"0","summary":"截至2026年4月21日收盘，金石亚药报收于10.18元，下跌1.17%，换手率1.46%，成交量5.0万手，成交额5101.58万元。董秘最新回复投资者： 目前行业内在仲丁基锂连续流规模化生产上已出现明显技术领先企业，该技术直接决定高难度创新药分子的可开发性与商业化效率。有无具体项目案例、产能规模及客户验证？公司暂不涉及您提及的业务。当日关注点来自交易信息汇总：4月21日主力资金净流出656.03万元，显示主力短期减持动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200006600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434","BK0028","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625053226","title":"股市必读：金石亚药（300434）4月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2625053226","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2625053226?lang=zh_cn&edition=full","pubTime":"2026-04-07 02:09","pubTimestamp":1775498951,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，金石亚药报收于10.06元，下跌3.45%，换手率2.9%，成交量9.93万手，成交额1.01亿元。董秘最新回复投资者： 贵司药厂生产线在海南是吗？公司具备稳定高效的产能释放能力，有力保障产品质量，为广大消费者提供优质的药品及保健品。交易信息汇总资金流向4月3日主力资金净流出1230.33万元，占总成交额12.16%；游资资金净流出343.67万元，占总成交额3.4%；散户资金净流入1573.99万元，占总成交额15.56%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700000873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","BK0239","300434"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616867073","title":"金石亚药(300434.SZ)：多潘立酮片中选接续采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2616867073","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2616867073?lang=zh_cn&edition=full","pubTime":"2026-03-02 15:57","pubTimestamp":1772438240,"startTime":"0","endTime":"0","summary":"金石亚药(300434.SZ)发布公告，公司全资一级子公司海南亚洲制药股份有限公司(以下简称“亚洲制药”)参加了国家组织集采药品协议期满品种接续采购办公室(以下简称“接续采购办公室”)组织的国家组织集采药品协议期满品种接续采购的投标工作。根据接续采购办公室2026年2月27日发布的《关于公布国家组织集采药品协议期满品种接续采购中选结果的通知》，亚洲制药产品多潘立酮片中选本次接续采购。","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/11.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/11.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408941.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"金石亚药(300434.SZ)：多潘立酮片中选接续采购","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","300434","BK0028","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614397027","title":"股市必读：金石亚药（300434）2月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2614397027","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2614397027?lang=zh_cn&edition=full","pubTime":"2026-02-27 02:06","pubTimestamp":1772129177,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘，金石亚药报收于10.7元，下跌1.2%，换手率1.43%，成交量4.88万手，成交额5244.45万元。董秘最新回复投资者： 请问公司是否与DeepSeek有相关业务或对接？目前，公司未涉及该类别药品的研发。公司积极关注机器人领域的进步和革新，审慎研究，但目前无涉及该领域的投资规划。当日关注点来自交易信息汇总：2月26日主力资金净流出279.87万元，散户资金净流入246.43万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700001162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300434","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614298041","title":"金石亚药：目前与DeepSeek暂无业务对接","url":"https://stock-news.laohu8.com/highlight/detail?id=2614298041","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2614298041?lang=zh_cn&edition=full","pubTime":"2026-02-26 20:53","pubTimestamp":1772110380,"startTime":"0","endTime":"0","summary":"证券之星消息，金石亚药(300434)02月26日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司是否与DeepSeek有相关业务或对接？金石亚药回复：尊敬的投资者，您好！公司已在积极推进大数据在提高决策效率、改善产销协同、优化客群管理等方面的应用；未来，也将持续关注人工智能给行业带来的创新和机会，寻求更多业务拓展可能性，目前与DeepSeek暂无业务对接。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600035444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300434"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787560707789,"stockEarnings":[{"period":"1week","weight":-0.0736},{"period":"1month","weight":0.1407},{"period":"3month","weight":0.1062},{"period":"6month","weight":0.1357},{"period":"1year","weight":0.1032},{"period":"ytd","weight":0.1623}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0099},{"period":"3month","weight":-0.0505},{"period":"6month","weight":-0.0433},{"period":"1year","weight":0.0356},{"period":"ytd","weight":-0.016}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川金石亚洲医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"23911人(较上一季度减少2.08%)","perCapita":"14307股","listingDate":"2015-04-24","address":"四川省成都市双流区九江镇万家社区","registeredCapital":"40174万元","survey":" 四川金石亚洲医药股份有限公司的主营业务是药品及保健食品研发、生产以及销售。公司的主要产品是呼吸系统用药、其他医药产品、保健品及食品、成套生产线、机械配件及其他。","listedPrice":10.57},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金石亚药(300434)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金石亚药(300434)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金石亚药,300434,金石亚药股票,金石亚药股票老虎,金石亚药股票老虎国际,金石亚药行情,金石亚药股票行情,金石亚药股价,金石亚药股市,金石亚药股票价格,金石亚药股票交易,金石亚药股票购买,金石亚药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金石亚药(300434)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金石亚药(300434)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}